Chelsea Therapeutics International develops prescription products in multiple therapeutic categories such as rheumatoid arthritis, psoriasis, and other inflammatory conditions.  Chelsea’s orphan drug candidate Northera is an oral therapeutic currently approved and marketed in Japan for the treatment of neurogenic orthostatic hypotension. Chelsea accelerates the development of its product candidates and expands its therapeutic pipeline through acquisitions and alliances. For more information visit the company’s Web site at www.chelseatherapeutics.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: